| Literature DB >> 23316806 |
Thiago L P Castro1, Nubia Seyffert, Rommel T J Ramos, Silvanira Barbosa, Rodrigo D O Carvalho, Anne Cybelle Pinto, Adriana Ribeiro Carneiro, Wanderson Marques Silva, Luis G C Pacheco, Christopher Downson, Maria P C Schneider, Anderson Miyoshi, Vasco Azevedo, Artur Silva.
Abstract
Corynebacterium pseudotuberculosis equi is a Gram-positive pathogenic bacterium which affects a variety of hosts. Besides the great economic losses it causes to horse-breeders, this organism is also known to be an important infectious agent to cattle and buffaloes. As an outcome of the efforts in characterizing the molecular basis of its virulence, several complete genome sequences were made available in recent years, enabling the large-scale assessment of genes throughout distinct isolates. Meanwhile, the RNA-seq stood out as the technology of choice for comprehensive transcriptome studies, which may bring valuable information regarding active genomic regions, despite of the still impeditive associated costs. In an attempt to increase the use of generated reads per instrument run, by effectively eliminating unwanted rRNAs from total RNA samples without relying on any commercially available kits, we applied denaturing high-performance liquid chromatography (DHPLC) as an alternative method to assess the transcriptional profile of C. pseudotuberculosis. We have found that the DHPLC depletion method, allied to Ion Torrent sequencing, allows mapping of transcripts in a comprehensive way and identifying novel transcripts when a de novo approach is used. These data encourage us to use DHPLC in future transcriptional evaluations in C. pseudotuberculosis.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23316806 PMCID: PMC3917459 DOI: 10.1111/1751-7915.12020
Source DB: PubMed Journal: Microb Biotechnol ISSN: 1751-7915 Impact factor: 5.813
Figure 1Chromatograms of a RNA sample before and after DHPLC fractionation for rRNA removal.A. Total RNA sample chromatographic profile. The two highest spikes correspond to ribosomal RNAs, and the red dashed lines delimitate the interval of run corresponding to the collected sample (mRNA) for downstream applications.B. Chromatographic profile of sample submitted to depletion with DHPLC. The green dashed lines virtually represent the previously selected area for sample collection. The proportion between the selected peak and the rRNA-related spikes appears to be more balanced in this case.
Figure 2Percentages of 16S rRNA depletion for each of four independently prepared biological replicates, in relation to the sigA gene mRNA levels. DHPLC and RiboMinus treatments were performed in a parallel way for each replicate. The asterisks indicate the cases where the levels of depletion observed for DHPLC were significantly different from those seen for RiboMinus, according to the software REST 2009.
Figure 3Classification of reads mapped against the CDS of C. pseudotuberculosis 31, according to terms of Gene Ontology.A. The identified transcripts were grouped by the biological processes to which their products are associated with. The horizontal bars indicate the amounts of grouped transcripts (genes) for each category, considering transcriptome results for both RiboMinus- and DHPLC-treated samples.B. In a similar way as before, the identified transcripts were sorted by their association with different classes of molecular functions.
Evaluation of ncRNAs present in C. pseudotuberculosis 31 by combining genomic with transcriptomic data
| Corresponding read counts (RNA-seq) | |||||
|---|---|---|---|---|---|
| ncRNAs predicted in the genome | Corresponding strand | Rfam bits score | Genomic stance | RiboMinus-treated sample | DHPLC-treated sample |
| tmRNA.1 | + | 136.29 | 605 717–606 098 | 1497 | 444 |
| RNaseP_bact_a.1 | − | 250.04 | 1 601 151–1 601 563 | 16 | 13 |
| cspA.1 | + | 55.15 | 231 046–231 384 | 12 | 5 |
| msiK.1 | − | 54.15 | 398 399–398 458 | 0 | 1 |
| Bacteria_small_SRP.1 | + | 55.35 | 149 269–149 361 | 0 | 1 |
| mraW.1 | − | 48.99 | 1 528 518–1 528 622 | 1 | 0 |
| 6C.1 | + | 32.18 | 223 511–223 577 | 1 | 0 |
| Cobalamin.2 | + | 72.55 | 724 215–724 451 | 2 | 0 |
| Cobalamin.1 | + | 74.77 | 924 216–924 412 | 0 | 0 |
| TPP.1 | + | 57.38 | 793 275–793 405 | 0 | 0 |
| yybP-ykoY.1 | − | 40.90 | 1 362 468–1 362 614 | 0 | 0 |
In reference to the whole-genome sequence of C. pseudotuberculosis 31 (NC_017730.1).
Statistics concerning the use of Oases software in the de novo approach
| rRNA depletion method | Non-mapped reads used | Assembly round | Total of contigs assembled | N50 of the contigs | Total base pairs assembled |
|---|---|---|---|---|---|
| RiboMinus | 85 600 | MergeK25 | 674 | 282 | 172 401 |
| MergeK27 | 1 225 | 283 | 318 679 | ||
| MergeK29 | 2 358 | 288 | 623 789 | ||
| MergeK31 | 4 595 | 291 | 1 229 563 | ||
| MergeK33 | 9 032 | 296 | 2 454 627 | ||
| MergeK35 | 17 822 | 310 | 5 195 511 | ||
| DHPLC | 150 090 | MergeK25 | 1 681 | 429 | 564 199 |
| MergeK27 | 2 740 | 441 | 949 402 | ||
| MergeK29 | 4 799 | 445 | 1 706 112 | ||
| MergeK31 | 8 834 | 447 | 3 200 016 | ||
| MergeK33 | 16 948 | 450 | 6 210 773 | ||
| MergeK35 | 32 659 | 456 | 12 134 747 |
Reads which did not match against CDS from C. pseudotuberculosis 31 (query coverage < 60% and similarity < 70%).
Statistics for the de novo approach after removal of redundant contigs using the Simplifier software
| rRNA depletion method | ||
|---|---|---|
| Non-redundant contigs (transcripts) | RiboMinus | DHPLC |
| Total number | 3 836 | 1 247 |
| Total base pairs | 1 392 183 | 449 947 |
| N50 | 399 | 455 |
| Longer | 1 712 | 2 237 |
| Smaller | 103 | 100 |
| With hits | 778 (407 620 bp) | 760 (295 852 bp) |
| Without hits | 3 058 (984 563 bp) | 487 (154 095 bp) |
Alignments performed against CDS of C. psedutoberculosis 31. Were considered negligible alignments < 30 bp with e-value > 1e-0.5).
New gene products found among the C. pseudotuberculosis 31 assembled transcripts
| Gene product | Number of matching contigs | Average size of contigs (bp) | Matching strain/product | Depletion method used |
|---|---|---|---|---|
| Hypothetical protein | 20 | 1510 | DHPLC/RiboMinus | |
| Hypothetical protein | 31 | 1235 | RiboMinus | |
| Hypothetical protein | 2 | 782 | DHPLC | |
| Hypothetical protein | 1 | 366 | RiboMinus | |
| Hypothetical protein | 2 | 1040 | RiboMinus | |
| Conserved hypothetical protein | 1 | 572 | RiboMinus | |
| Unknown protein | 1 | 344 | RiboMinus | |
| 8 | 1732 | DHPLC | ||
| 6 | 880 | DHPLC | ||
| 3 | 642 | DHPLC | ||
| 1 | 958 | DHPLC | ||
| Surface-anchored fimbrial protein | 8 | 958 | DHPLC | |
| Anaerobic dehydrogenase | 1 | 332 | DHPLC | |
| Nitrate reductase beta subunit | 2 | 554 | DHPLC | |
| nitrate reductase alpha subunit | 4 | 651 | DHPLC |
Only matches ≥ 100 bp with e-value ≤ 1e-05 were considered.